King Systems Gains Regulatory Approval for Products in China and Partners with Leading Chinese Distributor
King Systems has received approval by the State Food and Drug Administration of China (SFDA) to sell its anesthesia, respiratory care, and airway management products in the rapidly expanding Chinese market. During the product registration process, King Systems established a relationship with the Chinese based medical device company Beijing Gloryway Technology Co. Ltd and once granted the formal Certificate of Registration, has entered into an exclusive partnership with the company to distribute and sell King Systems’ products in China.
Don Dumoulin, King Systems’ CEO, said, “We are delighted to have this partnership with one of China’s leading medical import and distribution companies. Our core value of customer-focused products aligns with Gloryway’s emphasis on patient care and better patient outcomes in one of the largest medical markets in the world. We have an important opportunity to promote better patient care through this significant distribution partner in China and we are looking forward to a long and successful relationship with Gloryway and the medical professionals in China.”
Established in 2000, Beijing Gloryway Technology Co. Ltd. is a professional medical device company that has extensive experience in promoting and servicing products in the anesthesia, emergency care, intensive care, and respiratory care markets. Through Gloryway, all of King Systems’ circuits, masks, and breathing bags and many of its airway devices are now available to over 1,700 targeted hospitals with a combined total of 8 million general anesthetic procedures a year (the US market comprises around 19 million procedures a year). Their corporate office is in Beijing and has 30 full-time sales personnel. Gloryway has additional branch offices in Shanghai, Guangzhou and Wuhan as well as a complete distribution channel throughout the country.